|
Download
article
66kb
pdf? |
|
NEUROPROTECTION: UNDERSTANDING THE MODUS OPERANDUM OF GLUTAMATE
EXCITOTOXICITY
This review describes research using the Promega BDNF Emax
® ImmunoAssay System in a continuous medium-withdrawal
method for measuring BDNF release from NMDA-treated neurons. This method was initially developed by Ann M. Marini and colleagues
in 1998 in a landmark paper for ELISA-based neurotrophin detection.
|
